Lodi Giovanni, Sardella Andrea, Salis Annalisa, Demarosi Federica, Tarozzi Marco, Carrassi Antonio
Unità di Medicina e Patologia Orale, Università degli Studi di Milano, Milan, Italy.
J Oral Maxillofac Surg. 2010 Jan;68(1):107-10. doi: 10.1016/j.joms.2009.07.068.
To test the efficacy of a protocol in preventing the development of bisphosphonate-related osteonecrosis of the jaw (BRONJ) after tooth extraction.
In this prospective case series, consecutive subjects treated with intravenous bisphosphonates who needed tooth extraction underwent a protocol aimed at reducing the risk of BRONJ, based on local and systemic infection control by means of mechanical and chemical reduction of the local bacterial load plus antibiotic prophylaxis.
We performed 38 extractions in 23 patients treated with intravenous bisphosphonates, mainly zoledronate, for a mean of 17.5 months (range, 3-36 months). Five patients already had signs of BRONJ caused by tooth extractions performed elsewhere. The mean follow-up was 229.5 days (range, 14-965 days), and no case of BRONJ was recorded.
Despite the methodologic limitations of the study design, the proposed preventive protocol appears to reduce the risk of BRONJ after tooth extraction in a group of subjects treated with intravenous bisphosphonates.
测试一种方案在预防拔牙后双膦酸盐相关颌骨坏死(BRONJ)发生方面的疗效。
在这个前瞻性病例系列中,连续接受静脉注射双膦酸盐且需要拔牙的受试者接受了一种旨在降低BRONJ风险的方案,该方案基于通过机械和化学方法降低局部细菌负荷以及抗生素预防来进行局部和全身感染控制。
我们对23例接受静脉注射双膦酸盐(主要是唑来膦酸)治疗平均17.5个月(范围3 - 36个月)的患者进行了38次拔牙手术。5例患者已有在其他地方拔牙导致的BRONJ体征。平均随访时间为229.5天(范围14 - 965天),未记录到BRONJ病例。
尽管本研究设计存在方法学上的局限性,但所提出的预防方案似乎能降低一组接受静脉注射双膦酸盐治疗的受试者拔牙后发生BRONJ的风险。